XML 83 R27.htm IDEA: XBRL DOCUMENT v2.4.0.6
Schedule I, Condensed Financial Information of Parent Company
12 Months Ended
Dec. 31, 2012
Condensed Financial Statements, Captions [Line Items]  
Schedule I, Condensed Financial Information of Registrant (Parent Company Only)
CONDENSED FINANCIAL INFORMATION OF REGISTRANT
(PARENT COMPANY ONLY)
COVENTRY HEALTH CARE, INC.
CONDENSED BALANCE SHEETS
(in thousands) 
 
December 31,
2012
 
December 31,
2011
ASSETS
 
 
 
Current assets:
 
 
 
Cash and cash equivalents
$
321,166

 
$
634,592

Short-term investments
84,241

 
61,435

Other receivables, net
14,394

 
4,570

Other current assets
41,973

 
79,923

Total current assets
461,774

 
780,520

 
 
 
 
Long-term investments
509,421

 
504,022

Property and equipment, net
3,574

 
4,339

Investment in subsidiaries
5,507,880

 
5,123,007

Other long-term assets
62,894

 
93,444

Total assets
$
6,545,543

 
$
6,505,332

 
 
 
 
LIABILITIES AND STOCKHOLDERS’ EQUITY
 

 
 

Current liabilities:
 

 
 

Accounts payable and other accrued liabilities
$
119,617

 
$
315,175

Total current liabilities
119,617

 
315,175

 
 
 
 
Long-term debt
1,585,190

 
1,584,700

Notes payable to subsidiary
65,000

 
65,000

Other long-term liabilities
52,821

 
29,466

Total liabilities
1,822,628

 
1,994,341

 
 
 
 
Stockholders’ equity:
 

 
 

Common stock, $.01 par value; 570,000 authorized
197,080 issued and 134,573 outstanding in 2012
193,469 issued and 141,172 outstanding in 2011
1,971

 
1,935

Treasury stock, at cost; 62,507 in 2012; 52,297 in 2011
(1,920,749
)
 
(1,583,313
)
Additional paid-in capital
1,970,877

 
1,848,995

Accumulated other comprehensive income, net
69,220

 
60,469

Retained earnings
4,601,596

 
4,182,905

Total stockholders’ equity
4,722,915

 
4,510,991

Total liabilities and stockholders’ equity
$
6,545,543

 
$
6,505,332

 
See accompanying notes to the condensed financial statements.
CONDENSED FINANCIAL INFORMATION OF REGISTRANT
(PARENT COMPANY ONLY)
COVENTRY HEALTH CARE, INC.
CONDENSED STATEMENTS OF OPERATIONS
(in thousands) 
 
For the years ended December 31,
 
2012
 
2011
 
2010
Revenues:
 
 
 
 
 
Management fees charged to operating subsidiaries
$
302,718

 
$
261,798

 
$
208,453

 
 
 
 
 
 
Expenses:
 

 
 

 
 

Selling, general and administrative
198,665

 
200,005

 
170,524

Depreciation and amortization
575

 
1,297

 
939

Interest expense
101,576

 
101,174

 
82,590

Total expenses
300,816

 
302,476

 
254,053

 
 
 
 
 
 
Investment and other income, net
6,256

 
2,353

 
629

 
 
 
 
 
 
Income (loss) before income taxes and equity in net earnings of subsidiaries
8,158

 
(38,325
)
 
(44,971
)
 
 
 
 
 
 
(Provision) benefit for income taxes
(3,093
)
 
14,069

 
16,239

 
 
 
 
 
 
Income (loss) before equity in net earnings of  subsidiaries
5,065

 
(24,256
)
 
(28,732
)
 
 
 
 
 
 
Equity in net earnings of subsidiaries
481,998

 
567,361

 
467,348

 
 
 
 
 
 
Net earnings
$
487,063

 
$
543,105

 
$
438,616

 
 
 
 
 
 
Other comprehensive income (loss), net of tax:
 
 
 
 
 
Change in net unrealized gains (losses) on investments
8,751

 
19,388

 
(325
)
 
 
 
 
 
 
Comprehensive income
$
495,814

 
$
562,493

 
$
438,291

CONDENSED FINANCIAL INFORMATION OF REGISTRANT
(PARENT COMPANY ONLY)
COVENTRY HEALTH CARE, INC.
CONDENSED STATEMENTS OF CASH FLOWS
(in thousands)
 
For the years ended December 31,
 
2012
 
2011
 
2010
Net cash from operating activities
$
84,340

 
$
(170,263
)
 
$
(21,032
)
Cash flows from investing activities:
 

 
 

 
 

Capital expenditures, net
444

 
(2,414
)
 
518

Proceeds from the sales and maturities of investments
432,627

 
624,559

 
196,052

Purchases of investments and other
(435,100
)
 
(1,155,558
)
 

Capital contributions to subsidiaries
(134,000
)
 
(140,192
)
 
(142,271
)
Dividends from subsidiaries
265,175

 
745,403

 
530,589

Payments for acquisitions, net
(1,375
)
 
(7,616
)
 
(102,356
)
Net cash from investing activities
127,771

 
64,182

 
482,532

 
 
 
 
 
 
Cash flows from financing activities:
 

 
 

 
 

Proceeds from issuance of stock
87,671

 
44,624

 
15,484

Payments for repurchase of stock
(339,985
)
 
(336,219
)
 
(4,888
)
Repayment of debt
(233,903
)
 
(380,029
)
 

Repayment of note to subsidiaries

 

 
(4,235
)
Proceeds from issuance of debt

 
589,867

 

Excess tax benefit from stock compensation
12,210

 
7,619

 
2,925

Payments for cash dividends
(51,530
)
 

 

Net cash from financing activities
(525,537
)
 
(74,138
)
 
9,286

Net change in cash and cash equivalents
(313,426
)
 
(180,219
)
 
470,786

Cash and cash equivalents at beginning of period
634,592

 
814,811

 
344,025

Cash and cash equivalents at end of period
$
321,166

 
$
634,592

 
$
814,811

 
See accompanying notes to the condensed financial statements.
Parent Company [Member]
 
Condensed Financial Statements, Captions [Line Items]  
BASIS OF PRESENTATION
BASIS OF PRESENTATION 
Coventry Health Care, Inc. parent company financial information has been derived from its consolidated financial statements and should be read in conjunction with the consolidated financial statements included in this Form 10-K.  The accounting policies for the parent company are the same as those described in Note A, Organization and Summary of Significant Accounting Policies, to the consolidated financial statements.  The accounts of all subsidiaries are excluded from the parent company financial information. 
For information regarding the Company’s debt, commitments and contingencies and income taxes, refer to the respective notes to the consolidated financial statements.
SUBSIDIARY TRANSACTIONS
SUBSIDIARY TRANSACTIONS 
Through intercompany service agreements approved, if required, by state regulatory authorities, the parent company charges a management fee for reimbursement of certain centralized services provided to its subsidiaries. 
The captions “Capital contributions to subsidiaries” and “Dividends from subsidiaries” on the condensed statements of cash flows include amounts from our regulated and non-regulated subsidiaries. During 2012, 2011 and 2010 we received $214.7 million, $489.4 million and $319.4 million, respectively, in dividends from our regulated subsidiaries and infused $134.0 million, $122.0 million and $11.5 million, respectively, in capital contributions into our regulated subsidiaries.